Stockscreener 앱 받기
86.68
6.43%
5.24
시간 외 거래:
86.68
전일 마감가:
$81.44
열려 있는:
$80.94
하루 거래량:
1.23M
Relative Volume:
2.06
시가총액:
$2.71B
수익:
$492.68M
순이익/손실:
$-123.41M
주가수익비율:
-25.05
EPS:
-3.46
순현금흐름:
$-90.53M
1주 성능:
+12.57%
1개월 성능:
+38.22%
6개월 성능:
-15.58%
1년 성능:
+4.08%
1일 변동 폭
$79.69
$88.64
1주일 범위
$67.92
$88.64
52주 변동 폭
$55.92
$124.11
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - StockTitan
Director Abhijit Talwalkar Acquires 6,664 Shares of iRhythm Tech - GuruFocus.com
iRhythm Technologies, Inc. (NASDAQ:IRTC) CEO Sells $1,249,784.45 in Stock - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Director Acquires $500,866.24 in Stock - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Up 7.8%What's Next? - MarketBeat
iRhythm Technologies Inc (IRTC) Trading 4.41% Higher on Nov 4 - GuruFocus.com
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Harbor Capital Advisors Inc. - MarketBeat
Emerging Opportunities in the Ecg Sensor Patch Market - openPR
Q1 EPS Forecast for iRhythm Technologies Raised by Analyst - MarketBeat
Trend Tracker for (IRTC) - Stock Traders Daily
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts By Investing.com - Investing.com Australia
iRhythm Leaders Concealed Heart Monitor Deficiencies, Suit Says - Bloomberg Law
FDA clears iRhythm’s second 510(k) in response to warning letter - MedTech Dive
iRhythm Technologies Third Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Here’s Why iRhythm Technologies (IRTC) Slid in Q3 - Insider Monkey
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target - Yahoo Canada Finance
iRhythm Technologies (NASDAQ:IRTC) Price Target Lowered to $79.00 at Robert W. Baird - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2024 Earnings Call Transcript - Insider Monkey
Stephens Investment Management Group LLC Has $29.72 Million Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm stock holds Buy as Needham adjusts target, highlights strong Zio AT momentum - Investing.com Australia
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - MSN
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts - Investing.com
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies - Benzinga
iRhythm Technologies (NASDAQ:IRTC) Posts Quarterly Earnings Results, Misses Estimates By $0.71 EPS - MarketBeat
iRhythm Technologies Gains FDA Clearance for Zio Design Changes - MPO-mag
iRhythm Technologies (NASDAQ:IRTC) Shares Gap Down on Disappointing Earnings - MarketBeat
FDA clears second set of changes to iRhythm Zio AT to resolve warning letter - Mass Device
Needham & Company LLC Cuts iRhythm Technologies (NASDAQ:IRTC) Price Target to $96.00 - MarketBeat
IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates - MSN
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
FDA clears iRhythm's Zio AT device enhancements for 2025 By Investing.com - Investing.com Canada
FDA clears iRhythm's Zio AT device enhancements for 2025 - Investing.com India
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device - The Manila Times
iRhythm Technologies Announces Third Quarter 2024 Financial Results - The Manila Times
Earnings Preview For iRhythm Technologies - Benzinga
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy - The Manila Times
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? - Benzinga
iRhythm shares soar after FDA clears Zio AT device updates - MSN
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc.IRTC - Business Wire
iRhythm’s Zio AT design changes win FDA clearance - MedTech Dive
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock? - MSN
iRhythm Technologies (IRTC) to Release Quarterly Earnings on Wednesday - MarketBeat
BTIG bullish on iRhythm stock, FDA clearance partially lifts regulatory overhang - Investing.com Canada
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock Position Raised by Allspring Global Investments Holdings LLC - MarketBeat
Truist raises iRhythm stock target, keeps at Buy list on FDA approval By Investing.com - Investing.com South Africa
Truist raises iRhythm stock target, keeps at Buy list on FDA approval - Investing.com Nigeria
iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve - Seeking Alpha
IRhythm Earns FDA Nod For Zio AT After Warning Letter - MPO-mag
How to Take Advantage of moves in (IRTC) - Stock Traders Daily
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
1.00%
자본화:
|
볼륨(24시간):